Combien coute le ticket médicament?

Research Spending Per New Drug
Company	Ticker	Number of drugs approved	R&D Spending Per Drug ($Mil)	Total R&D Spending 1997-2011 ($Mil)
AstraZeneca	AZN	5	11,790.93	58,955
GlaxoSmithKline	GSK	10	8,170.81	81,708
Sanofi	SNY	8	7,909.26	63,274
Roche Holding AG	RHHBY	11	7,803.77	85,841
Pfizer Inc.	PFE	14	7,727.03	108,178
Johnson & Johnson	JNJ	15	5,885.65	88,285
Eli Lilly & Co.	LLY	11	4,577.04	50,347
Abbott Laboratories	ABT	8	4,496.21	35,970
Merck & Co Inc	MRK	16	4,209.99	67,360
Bristol-Myers Squibb Co.	BMY	11	4,152.26	45,675
Novartis AG	NVS	21	3,983.13	83,646
Amgen Inc.	AMGN	9	3,692.14	33,229
Sources: InnoThink Center For Research In Biomedical Innovation; Thomson Reuters Fundamentals via FactSet Research Systems